MAZE THERAPEUTICS INC (MAZE:NASDAQ)
$31.69 0.62 (1.9955%)
Analysed MAZE THERAPEUTICS INC (MAZE:NASDAQ) News Sources
Maze Therapeutics Announces Appointments to Its Board of Directors
13-08-2026
yahoo.com
Maze Therapeutics to Participate in Three Upcoming Investor Conferences
02-09-2026
yahoo.com
Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000
11-09-2026
fool.com
Maze Therapeutics Shares Rise 2.9% After CIBC Initiates Coverage
23-09-2026
advfn.com
Maze Therapeutics (MAZE) Shares Moved, So What Is Driving Attention Now?
25-09-2026
yahoo.com
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?
29-09-2026
yahoo.com
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
06-10-2026
yahoo.com
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
13-10-2026
yahoo.com
How Much Upside is Left in Maze Therapeutics, Inc. (MAZE)? Wall Street Analysts Think 123.39%
19-10-2026
yahoo.com
What Makes Maze Therapeutics, Inc. (MAZE) a New Buy Stock
19-10-2026
yahoo.com
What is the current price of MAZE THERAPEUTICS INC (MAZE:NASDAQ)?
The current price of MAZE THERAPEUTICS INC (MAZE:NASDAQ) is $31.69.
MAZE THERAPEUTICS INC (MAZE:NASDAQ) absolute price change since previous trading day?
The absolute price change of MAZE THERAPEUTICS INC (MAZE:NASDAQ) since the previous trading day is $0.62.
MAZE THERAPEUTICS INC (MAZE:NASDAQ) percentage price change since previous trading day?
The percentage price change of MAZE THERAPEUTICS INC (MAZE:NASDAQ) since the previous trading day is 1.9955%.
What is the most recent average sentiment score for MAZE THERAPEUTICS INC (MAZE:NASDAQ)?
The most recent average sentiment score for MAZE THERAPEUTICS INC (MAZE:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for MAZE THERAPEUTICS INC (MAZE:NASDAQ)?
The most recent sentiment for MAZE THERAPEUTICS INC (MAZE:NASDAQ) is .
SEC-8K** Filing Available For MAZE THERAPEUTICS INC (MAZE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.